On November 1, 2021 Viracta Therapeutics, Inc. (NASDAQ: VIRX), a precision oncology company targeting virus-associated malignancies, reported that company management is scheduled to present and host one-on-one meetings at the following upcoming investor conferences (Press release, Viracta Therapeutics, NOV 1, 2021, View Source [SID1234594009]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Credit Suisse 30th Annual Healthcare Conference (virtual)
Conference Dates:
November 8 – 12, 2021
Presentation Date:
November 11, 2021
Presentation Time:
1:50 PM ET
Format:
Corporate presentation
Jefferies London Healthcare Conference (in-person)
Conference Dates:
November 16 – 17, 2021
Presentation Date:
November 17, 2021
Presentation Time:
10:40 AM GMT/ 5:40 AM ET
Format:
Corporate presentation
Piper Sandler 33rd Annual Healthcare Conference (virtual)
Conference Dates:
November 29 – December 2, 2021
Presentation Available:
November 22, 2021, at 10:00 AM ET
Format:
Corporate presentation
Evercore ISI 4th Annual HealthCONx Conference (virtual)
Conference Dates:
November 29 – December 2, 2021
Presentation Date:
December 2, 2021
Presentation Time:
3:55 PM ET
Format:
Fireside chat
A live webcast of each of the presentations will be available under "Events and Webcasts" in the Investors section of the Viracta website at View Source Replays of each webcast will be archived on the Viracta website for at least 30 days following the presentation.